Pharmaceutical

Modern AI implementation requires a sophisticated infrastructure to handle prompt management, retrieval pipelines, model routing, and safety monitoring across the entire value chain. Despite a global investment of 250 billion dollars in artificial intelligence last year, the pharmaceutical sector

Researchers can now screen thousands of potential drug compounds more quickly by observing how human cells interact with experimental treatments in a controlled laboratory setting. This breakthrough, led by experts from the Florey Institute and Monash University, marks a turning point in the study

The Target Nexus platform is projected to drive eighty percent of portfolio decisions for Roche by 2026 as the company pursues full AI independence. This strategic pivot signals a monumental shift in how multinational pharmaceutical giants allocate their resources, moving away from fragmented

Fluctuating temperatures and damp air act as direct physical irritants to the respiratory tract, making it critical to establish antihistamine protocols before flare-ups occur. As the vibrant hues of autumn begin to settle, the shifting environment demands more than just a change in wardrobe; it

The Korean Pharmaceutical Association has documented cases where patients exploited telemedicine to obtain multiple prescriptions for potent antidepressants from various institutions simultaneously. This stark reality highlights the profound challenges facing South Korea’s pharmaceutical sector as

The collapse of specialized manufacturing partners can derail years of clinical validation, highlighting the extreme vulnerability of the medical technology supply chain during economic volatility. This systemic fragility underscores a profound contradiction within the current healthcare landscape